ANGLE plc receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Angle Plc (AGLE)
Assess today's live Angle Plc (AGLE) share price, performance and insights using our live London: AGLE stock exchange data.
Analyse the historical data and Angle Plc share price performance charts on this page. Our technical summary section provides analysis on Angle share price buy/sell indicators using real-time data (or discuss the Angle (AGLE) stock price today with other investors in the Angle LON share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current LON AGLE share price (ISIN: GB0034330679) to enhance your trading decisions with our free investment tools and resources.
What Is the Angle Plc Share Price Today?
The Angle share price today is 13.00.
What Is the Stock Symbol for Angle Plc
The stock symbol (or 'ticker') for Angle Plc is "AGLE."
What Stock Exchange Does Angle Plc Trade On?
Angle Plc is listed and trades on the London stock exchange.
Is Angle Plc a Good Stock to Buy?
Determining whether Angle Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Angle Plc share price performance charts on this page. Our technical summary section provides analysis on Angle share price buy/sell indicators using real-time data (or discuss the Angle (AGLE) stock price today with other investors in the Angle LON share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current LON AGLE share price (ISIN: GB0034330679) to enhance your trading decisions with our free investment tools and resources.
What Is the Angle Plc Share Price Today?
The Angle share price today is 13.00.
What Is the Stock Symbol for Angle Plc
The stock symbol (or 'ticker') for Angle Plc is "AGLE."
What Stock Exchange Does Angle Plc Trade On?
Angle Plc is listed and trades on the London stock exchange.
Is Angle Plc a Good Stock to Buy?
Determining whether Angle Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
13.00
+0.50(+4.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.50
13.85
52 wk Range
7.11
25.08
AGLE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.5013.85
52 wk Range
7.1125.08
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AGLE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
68.50
Upside
+426.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- EasyJet, inflation, Tesla and Netflix to star: Week Ahead
- Proactive Investors
- 1
- ANGLE plc PT receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- ANGLE plc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - EasyJet, inflation, Tesla and Netflix to star: Week Ahead
- Proactive Investors
- 1
- ANGLE plc PT receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Angle Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with high analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal transition; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including enumeration of epithelial and mesenchymal CTC populations; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. ANGLE plc has a strategic partnership with Bio View Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer; and agreement with NuProbe USA, Inc. to use its proprietary pan-cancer next generation sequencing (NGS) panel. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Compare AGLE to Peers and Sector
Metrics to compare | AGLE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAGLEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −1.6x | −0.6x | |
PEG Ratio | −0.11 | 0.01 | 0.00 | |
Price/Book | 1.6x | 1.2x | 2.6x | |
Price / LTM Sales | 19.9x | 2.6x | 3.1x | |
Upside (Analyst Target) | - | 100.5% | 50.2% | |
Fair Value Upside | Unlock | 13.4% | 7.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 68.50
(+426.92% Upside)
Earnings
Latest Release
Apr 21, 2023
EPS / Forecast
-0.09 / --
Revenue / Forecast
1.04M / --
People Also Watch
FAQ
What Is the Angle (AGLE) Stock Price Today?
The Angle stock price today is 13.00
What Stock Exchange Does Angle Trade On?
Angle is listed and trades on the London stock exchange.
What Is the Stock Symbol for Angle?
The stock symbol for Angle is "AGLE."
What Is the Angle Market Cap?
As of today, Angle market cap is 42.90M.
What is Angle Earnings Per Share?
The Angle EPS is -0.068.
From a Technical Analysis Perspective, Is AGLE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.